Speaking at the recent British Society of Rheumatology 2023 annual scientific meeting, Dr Mark Russell, NIHR Doctoral Fellow at King’s College London, shares findings of a recent meta-analysis looking at the risk of malignancy with different JAK inhibitors across multiple disease indications. Watch to find out more
VIDEO: Dr Mark Russell shares new findings on JAKi cancer risk
22 May 2023